INTRODUCTION
Renal cell carcinoma with TFEB gene rearrangement was originally recognized based on translocation t(6;11) occurring in children. [1] The unique histologic appearance of these tumors was first characterized as including large cells with clear or eosinophilic cytoplasm and a second population of smaller cells with scant cytoplasm arranged around hyaline basement membrane material, resembling rosettes. [1, 2] More recently, however, other studies have found that this unique morphology is not always straightforward, and that some molecularly-confirmed TFEB rearrangement tumors may mimic clear cell renal cell carcinoma, chromophobe renal cell carcinoma, tubulocystic renal cell carcinoma, epithelioid angiomyolipoma, multilocular cystic renal cell carcinoma, or high-grade unclassified renal cell carcinoma. [3] [4] [5] [6] One recent series included a single example that was extensively hyalinized and ossified. [4] Herein we report another such example with extensive sclerosis and metaplastic bone formation, nearly obscuring the epithelial nature of the tumor, suggesting that this tendency for sclerosis may be a recurring pattern of TFEB renal cell carcinoma. A C C E P T E D M A N U S C R I P T 
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Bacterial artificial chromosome (BAC) clones from the immediately flanking genomic regions of TFEB and TFE3 genes were used to generate dual color break-apart Deceptive patterns of TFEB translocation renal cell carcinoma that have been recently recognized include examples with multilocular cystic, [3] oncocytic, [4] eosinophilic papillary, [4] high-grade unclassified, [3, 5] chromophobe renal cell carcinomalike, [5] tubulocystic, [6] epithelioid angiomyolipoma-like, [5] or clear cell-like [1, 5] features. One example from a series of 8 tumors reported by Argani and colleagues was noted to be extensively sclerotic and ossified, [4] occurring in a 37 year-old man, similar to
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Williamson et al -Sclerosing TFEB Renal Cell Carcinoma 6 the case reported here. Both in the report by Argani et al and the current case, the tumors yielded labeling for PAX8, melan-A, cathepsin K, and a lesser extent of labeling for HMB45, without the appreciable dual cell population pattern that is characteristic of TFEB translocation-associated tumors. [4] Thus, it appears that an extensively sclerotic histologic pattern, although likely less common than the prototypical appearance, potentially represents a recurring histology of TFEB rearrangement-associated renal cell carcinoma.
Since this differs from the distinctive morphology originally reported, pathologists should be aware of this unusual phenomenon to facilitate diagnostic classification.
In this case, we were prompted to consider several differential diagnostic possibilities based on the unusual tumor histology: Clear cell renal cell carcinoma is the most common subtype of renal cell carcinoma, and therefore presumably the most likely to undergo extensive degenerative changes. In the current case, negative reactivity for carbonic anhydrase IX, combined with positive labeling for melanocytic markers (HMB45 and melan-A) and cathepsin K [9] argued against a diagnosis of clear cell renal cell carcinoma and argued in favor of a translocation-associated tumor, which was confirmed by FISH. Due to the mixture of epithelioid clear to eosinophilic cells, thick blood vessels, and fat, we also considered the possibility of an unusual manifestation of angiomyolipoma.
Calcification associated with fat in a renal mass is generally considered presumptive evidence for renal cell carcinoma radiographically, [10, 11] most likely representing bone marrow fat associated with metaplastic bone. [10, 12] However, rare calcification in angiomyolipoma has been reported. [10] Despite that positivity for melanocytic markers and cathepsin K would be a shared feature of both TFEB translocation renal cell carcinoma and angiomyolipoma, the tumor cells in this case were negative for smooth muscle
Williamson et al -Sclerosing TFEB Renal Cell Carcinoma 7 markers (smooth muscle actin, caldesmon) and positive for epithelial markers (keratin AE1/AE3 and PAX8), resolving this distinction. Finally, we also considered the possibility of hemangioblastoma, based on the composition by foamy-appearing cells with clear to eosinophilic cytoplasm. Although much more common in the central nervous system, hemangioblastoma has recently been increasingly recognized to occur as a primary renal tumor, and several studies have recently found unexpected aberrant positivity for PAX8. [13] [14] [15] Although few primary renal hemangioblastomas have been thoroughly characterized with a broad immunohistochemical panel, these tumors appear to be consistently positive for inhibin, and negative for melanocytic markers and cathepsin K, and predominantly negative for epithelial markers other than PAX8. [13] [14] [15] [16] Interestingly, PAX2 and PAX8 have been found to show negative staining in central nervous system hemangioblastomas, supporting a role as diagnostic markers to distinguish hemangioblastoma from metastatic renal cell carcinoma, both of which are prone to occur in von Hippel-Lindau disease patients. [17] The aberrant PAX8 positivity in primary kidney hemangioblastomas has therefore been hypothesized to reflect origin from an organ-specific cell type through unknown mechanisms. [13, 15] Conversely, inhibin positivity has also been reported in some renal cell carcinomas, blurring the distinction between renal cell carcinoma and hemangioblastoma of the kidney in some cases. [18, 19] In summary, here we report an example of extensively sclerotic and ossified renal cell carcinoma with TFEB rearrangement, which showed positive immunohistochemical labeling for keratin AE1/AE3 and PAX8, patchy labeling for melan-A and cathepsin K, and very limited labeling for HMB45. Combined with one prior such example from a series of TFEB rearrangement renal cell carcinomas, it appears that this may be a less common but recurring histologic pattern of TFEB renal cell carcinoma, which can be distinguished from angiomyolipoma and other renal cell carcinoma subtypes via immunohistochemistry and molecular studies. A C C E P T E D M A N U S C R I P T
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